Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05726929

Algology in Oncology Osteopathic Support (ALGOS)

Conditions: Breast Cancer, Neuropathic Pain

Sex: All
Ages: 18 Years – 80 Years
Phase: NA
Enrollment: 120
Sponsor: Institut Toulousain d'Ostéopathie

Location: France

Summary

The aim of the study is to evaluate the Impact of add-on osteopathic treatment in the algological course of patients treated for breast cancer : Randomized Controlled Trial.

Eligibility Criteria

Inclusion Criteria:Major patients with sequelae of pain following breast cancer surgery with or without other treatments and who have been in pain for more than 3 months. Neuropathic pain may be experienced in the upper and middle chest, armpit and/or arm ipsilateral to the surgery and/or radiotherapy.Exclusion Criteria:Unemancipated minors, protected adults and adults who are not in a position to give their consent are excluded from the protocol.Patients who do not have social security coveragePatients with non-iatrogenic peripheral neuropathyPatients who do not speak FrenchPatients with confusional disordersPatients with a brain tumourAny patient with healing disorders at the surgical site

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05726929). StuddyBuddy aggregates publicly available trial information.